Answers are grounded in this paper and cite their sources.
Viloxazine is a chiral norepinephrine reuptake inhibitor for which reliable enantiomeric analysis is essential to ensure pharmacological consistency, safety, and regulatory compliance. This study presents a validated, rapid, and efficient supercritical fluid chromatographic (SFC) method for the enantiomeric separation and quantification of viloxazine using an immobilized amylose‐based chiral stationary phase. Baseline separation was obtained within 8 min with excellent chromatographic performance and resolution (Rs) of 3.09 and symmetric peak shapes. Although enantiomeric separation of viloxazine under SFC conditions has been reported previously, earlier studies primarily focused on chromatographic selectivity and chiral recognition mechanisms. In contrast, the present method was comprehensively validated as per ICH Q2(R2) recommendations and demonstrated excellent linearity (r = 0.9996 for both enantiomers), high precision (%RSD < 0.5% for peak area), good sensitivity, LOD, i.e., Limit of Detection (0.016 mg mL −1 ), and LOQ, i.e., Limit of Quantification (0.040 mg mL −1 ). Compared with previously reported NP‐HPLC and PO‐HPLC methods, the developed SFC method provides a shorter analysis time and lower organic solvent consumption while maintaining comparable analytical sensitivity. A comparative analytical greenness assessment using the AGREE metric yielded scores of 0.61, 0.58, and 0.56 for the developed SFC, PO‐HPLC, and NP‐HPLC methods, respectively, indicating a comparatively favorable overall environmental profile for the SFC method. These advantages establish the developed method as a practical and reliable analytical approach for routine enantiomeric purity assessment of viloxazine in pharmaceutical quality‐control laboratories.
No takes yet. Share an insight, caveat, or question.
Mannem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: